4.5 Article

Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes

Journal

CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 162, Issue 2, Pages 197-209

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1365-2249.2010.04237.x

Keywords

CFSE; ELISPOT; immunoblot; T cell assays; tetramer; type 1 diabetes

Categories

Funding

  1. Juvenile Diabetes Research Foundation (JDRF) [5-2009-413]

Ask authors/readers for more resources

P>Type 1 diabetes (T1D) is an autoimmune disease caused by the T cell-mediated destruction of the pancreatic insulin-producing beta cells. Currently there are no widely accepted and standardized assays available to analyse the function of autoreactive T cells involved in T1D. The development of such an assay would greatly aid efforts to understand the pathogenesis of T1D and is also urgently required to guide the development of antigen-based therapies intended to prevent, or cure, T1D. Here we describe some of the assays used currently to detect autoreactive T cells in human blood and review critically their strengths and weaknesses. The challenges and future prospects for the T cell assays are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available